IP Library › Granted Patent US 7,563,866
Granted Patent B2
US 7,563,866 · App. 11/102,883 · Granted Jul 21, 2009

Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses

Assignee: ImVisioN GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,563,866
App. No.
11/102,883
Granted
Jul 21, 2009
Kind
B2
Abstract

Modular antigen transporter molecules (MAT molecules), which are used as vaccines and for the treatment of allergies, include three modules: a translocation module which brings about transport of the MAT molecule into the interior of the cell; a targeting module which directs the MAT molecule to intracellular organelles involved in antigen processing and loading; and an antigen module which contains an allergen.

Claims (10)

1. A modular antigen transport molecule (MAT molecule) comprising

at least one translocation module which brings about transport of the MAT molecule from an extracellular space into an interior of a cell,

at least one targeting module which brings about transport of the MAT molecule intracellularly to organelles which are involved in processing of antigens or loading of major histocompatibility (MHC) molecules with antigens, and

at least one antigen module which determines the specificity of an immune response modulated by the MAT molecule in an individual,

wherein the modules are coupled to one another by covalent linkages; and wherein the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35 and SEQ ID NO: 36.

2. The MAT molecule of claim 1 , wherein the at least one antigen module is a fel d 1 antigen module and the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO:23 and SEQ ID NO: 24.

3. The MAT molecule of claim 1 , wherein the at least one antigen module is a bet v 1 antigen module and the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 25 and SEQ ID NO: 26.

4. The MAT molecule of claim 1 , wherein the at least one antigen module is a der p 1 antigen module and the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 27 and SEQ ID NO: 28.

5. The MAT molecule of claim 1 , wherein the at least one antigen module is a api g 1 antigen module and the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, and SEQ ID NO: 32.

6. The MAT molecule of claim 1 , wherein the at least one antigen module is a pla 2 antigen module and the MAT molecule is a protein or polypeptide having the sequence set forth in a SEQ ID NO: selected from the group consisting of SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35 and SEQ ID NO: 36.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2013
From: IMVISION GMBH
To: BOEHRINGER INGELHEIM VETMEDICA GMBH
Reel/Frame 029685/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2005
From: LAMPING, NORBERT; CRAMERI, RETO; FLUCKIGER, SABINE; DAIGLE, ISABELLE
To: IMVISION GMBH
Reel/Frame 016913/0671 →
Priority Claims (1)
EP 2022774 · Oct 11, 2002 · regional
Continuity (2)
Continuation In Part PCTEP031119000 · Oct 9, 2003
Related Publication 20050281816A1 · Dec 22, 2005